MedPath

KETOPHENE

KETOPHENE - 70332-101

Approved
Approval ID

271e6176-698a-30dd-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 21, 2016

Manufacturers
FDA

California Pharmaceuticals, LLC

DUNS: 021420944

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

KETOPHENE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70332-101
Product Classification
G
Generic Name
KETOPHENE
Product Specifications
Effective DateJuly 21, 2016
FDA Product Classification

Drug Labeling Information

INSTRUCTIONS FOR USE SECTION

LOINC: 59845-8Updated: 7/21/2016

Instructions for Preparation

Page 1
Page 2

NDC 70332-101-01 For Prescription Compounding Only Rx only

RapidPaq™ Ketophene™

(20% Ketoprofen topical cream kit)

RapidPaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).

Description:

This kit contains active and inactive materials to prepare approximately 167 grams of ketoprofen topical cream.This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

Active Ingredients:

- 33.5 g Ketoprofen, USP

Inactive Ingredients:

- 100 g RapidPaq Cream Base (D.I Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexlglycerin,

Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA,)

- 33.5 g ethoxy diglycol

- Spatula

-Instructions

Pharmacist instructions for Preparation

1 Remove and Inspect the Contents of the Kit

Ensure that all components are present. Ensure that the safety seals are present on the Ketoprofen, ethoxy diglycol and RapidPaq Cream Base. If components are missing or not intact, do not use the kit.

2 Prepare for Mixing

Wear gloves and eye protection during mixing operations. Remove cap and seal from the RapidPaq Cream Base. Break the seal and remove the cap from the Ketoprofen and ethoxy diglycol.

3 Dissole the Ketoprofen

Transfer approximately 2/3 of the ethoxy diglycol to the Ketoprofen jar. With the supplied spatula, mix them together until they are mostly dissolved. Transfer the Ketoprofen mix to the jar of RapidPaq Cream Base. Transfer the remaining 1/3 of ethoxy diglycol to the Ketoprofen jar and repeat the mixing process. transfer the remaining Ketoprofen mix to the jar of RapidPaq Cream Base.

4 Complete the Mixing Process

Using the spatula, mix the RapidPaq Crean base jar that now contains the ethoxy diglycol and Ketoprofrn ingredients thoroughly for about 2 minutes or until fully dissolved.

5 Relabel the Resulting Cream

Label the resulting topical cream as required for prescription products. Ensure that the original RapidPaq Cream Base label is removed or obscured, since the original label is no longer accurate once the cream is prepared.

Discard the spatula.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the topical cream between 15-30°C (59-86°F). The resulting final topical cream is stable for up to eight weeks.

U.S. Patents Pending

Repacked and Distributed by:

California Pharmaceuticals, LLC

768 Calle Plano

Camarillo, CA 93012

CS113-A1 rev 2

California

PHARMACEUTICALS LLC

Ketophehe Kit Instructions 1

Ketophehe Kit Instructions 2

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KETOPHENE - FDA Drug Approval Details